肝癌切除术麻醉的优化策略:前锯肌平面阻滞-腹直肌后鞘阻滞-全身麻醉

来源 :中华麻醉学杂志 | 被引量 : 0次 | 上传用户:dasmine
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:评价前锯肌平面阻滞-腹直肌后鞘阻滞-全身麻醉用于肝癌切除术的优化效果。方法:择期全麻下行肝癌切除术患者100例,年龄30~64岁,体重指数18~30 kg/mn 2,ASA分级Ⅱ或Ⅲ级,肝功能Child-Pugh分级A或B级,采用随机数字表法分为2组(n n=50):前锯肌平面阻滞联合腹直肌后鞘阻滞组(S组)和胸椎旁神经阻滞组(T组)。S组采用0.375%罗哌卡因在超声引导下行前锯肌平面阻滞(20 ml)联合腹直肌后鞘阻滞(10 ml),T组采用0.375%罗哌卡因在超声引导下行Tn 7和Tn 9椎旁神经阻滞(各15 ml)。静脉注射咪达唑仑、丙泊酚、舒芬太尼和顺式阿曲库铵诱导麻醉,静脉输注丙泊酚和瑞芬太尼、间断静脉注射顺式阿曲库铵维持麻醉,术中维持BIS值40~60。术毕采用舒芬太尼和氟比洛芬酯行PCIA,VAS评分>3分时静脉注射羟考酮5 mg补救镇痛。记录神经阻滞起效时间和操作时间;记录术中舒芬太尼、瑞芬太尼用量和切皮后30 min内心血管事件发生情况;记录术后48 h内PCA有效按压次数和补救镇痛情况;分别于术前24 h、术后24和48 h时行40项恢复质量量表(QoR-40)评分;分别于术前24 h、术后24 h和7 d时抽取外周静脉血标本,测定血清IL-17和干扰素γ的浓度。记录术后首次排气时间、首次下床时间及住院时间。记录术后48 h内恶心呕吐、呼吸抑制、皮肤瘙痒、穿刺部位感染和气胸等不良反应发生情况。n 结果:与T组比较,S组神经阻滞操作时间缩短,术中低血压发生率降低(n P0.05)。2组术后未见不良反应发生。n 结论:相对于胸椎旁神经阻滞联合全身麻醉而言,前锯肌平面阻滞-腹直肌后鞘阻滞-全身麻醉用于肝癌切除术,神经阻滞操作时间缩短,术中低血压发生率降低。“,”Objective:To evaluate the optimization strategy of anesthesia for liver cancer resection using serratus anterior plane block-posterior rectus sheath block-general anesthesia.Methods:One hundred patients, aged 30-64 yr, with body mass index of 18-30 kg/mn 2, of American Society of Anesthesiologists physical status Ⅱ or Ⅲ, with liver function Child-Pugh grade A or B, scheduled for elective liver cancer resection under general anesthesia, were divided into serratus anterior plane block combined with posterior rectus sheath block group (group S, n n=50) and thoracic paravertebral block group (group T, n n=50) using a random number table method.Ultrasound-guided serratus anterior plane block (20 ml) combined with posterior rectus sheath block (10 ml) was performed using 0.375% ropivacaine in group S. Ultrasound-guided paravertebral block was performed at Tn 7 and Tn 9(15 ml for each site) with 0.375% ropivacaine in group T. Anesthesia was induced with intravenous midazolam, propofol, sufentanil and cisatracurium and maintained with intravenous infusion of propofol and remifentanil and intermittent intravenous boluses of cisatracurium.BIS value was maintained at 40-60 during operation.Patient-controlled intravenous analgesia (PCIA) was performed with sufentanil and flurbiprofen at the end of operation, and oxycodone 5 mg was intravenously injected as rescue analgesic when the VAS score>3.The onset time and operation time of nerve block were recorded.The intraoperative consumption of sufentanil and remifentanil and occurrence of cardiovascular events within 30 min after skin incision were recorded.The effective pressing times of PCA and requirement for rescue analgesia within 48 h after operation were recorded.The recovery quality was measured using the 40-item quality of recovery questionnaire at 24 h before surgery and 24 and 48 h after surgery.Peripheral venous blood samples were collected at 24 h before surgery and 24 h and 7 days after surgery to determine the concentrations of interleukin-17 and interferon-gamma in serum.The postoperative time to first flatus, first ambulation time, and length of hospital stay were recorded.The nausea and vomiting, respiratory depression, skin itching, puncture site infection, pneumothorax and other adverse reactions were recorded within 48 h after operation.n Results:Compared with group T, the operation time of nerve block was significantly shortened, the incidence of intraoperative hypotension was decreased (n P0.05). No postoperative adverse reactions were found in either group.n Conclusions:Compared with thoracic paravertebral nerve block combined with general anesthesia, serratus anterior plane block-posterior rectus sheath block-general anesthesia has shorter operation time and lower incidence of intraoperative hypotension when used for liver cancer resection.
其他文献
前庭性偏头痛(VM)是一种以前庭症状反复发作常伴有偏头痛特征的致残性疾病.VM发病机制目前尚未完全清楚,多数研究认为与离子通道缺陷、皮层扩布性抑制、炎症及遗传易感性有关.头颅磁共振、听力学及前庭功能检查等临床检查对VM的诊断尚无特异性,但有助于排除其他诊断.VM根据发作情况,可分为急性期治疗和预防性治疗,临床上应根据患者实际情况进行个体化治疗.本文对VM的发病机制、临床特点、辅助检查、诊断及治疗进行综述,旨在帮助临床医师进一步认识VM.
目的:评价舒更葡糖钠用于ASA分级Ⅲ或Ⅳ级高风险手术患者术后拮抗神经肌肉阻滞的安全性。尤其着重评估了心脏不良事件以及其他预先指定的临床关注不良事件的影响。方法:符合ASA分级Ⅲ或Ⅳ级标准的患者,根据ASA分级和神经肌肉阻滞剂(罗库溴铵或维库溴铵)进行随机分组,新斯的明/格隆溴铵组:中度神经肌肉阻滞;舒更葡糖钠2 mg/kg组,中度神经肌肉阻滞;舒更葡糖钠4 mg/kg组,深度神经肌肉阻滞;舒更葡糖钠16 mg/kg组,深度神经肌肉阻滞(仅罗库溴铵)。主要研究终点包括治疗期间窦性心动过缓、窦性心动过速和其他
目的:评价肩胛舌骨肌下前路肩胛上神经阻滞(SSNB)用于全麻肩关节镜手术患者的效果。方法:择期行肩关节镜手术患者60例,性别不限,年龄18~64岁,ASA分级Ⅰ或Ⅱ级,BMI 18~30 kg/mn 2,采用随机数字表法分为2组(n n=30):SSNB组(S组)和肌间沟臂丛神经阻滞(ISB)组(I组)。麻醉诱导前,I组在Cn 5-6神经根之间、S组在肩胛舌骨肌下的前路肩胛上神经周围分别注射0.375%盐酸罗哌卡因15 ml。注药后30 min,记录膈肌活动度,膈肌麻痹发生情
唑来膦酸是一种常用的抗骨质疏松药物,每年使用1次. 该药使用后易出现急性期反应,表现为发热、关节痛、肌痛、流感样症状等,但多在3d内出现,且较轻. 本文报道1例女性患者使用唑来膦酸9d后出现右侧躯干转移性剧烈疼痛,伴发热.
患者女性,年龄52岁,身高160 cm,体重52.5 kg,因“体检发现左侧肾上腺结节2周”入院。入院后发现血压增高且伴有低钾血症,予以硝苯地平片控制血压并静脉补钾等治疗,术前诊断为左侧肾上腺肿瘤:醛固酮瘤?高血压2级,高危。拟于全身麻醉下行后腹腔镜下左侧肾上腺肿瘤切除术。术前心电图、心脏彩超、胸部CT检查以及血常规、肝肾功能、凝血功能、电解质等未见明显异常。
期刊
(1)一般情况:患者男性,年龄77岁,体重72 kg,身高168 cm,BMI 25.5 kg/mn 2。发现乙肝抗原阳性30年,1月前无明显诱因出现全身酸软乏力、黄疸,便血5 d。以抗感染、纠正凝血功能等对症支持治疗,拟在全身麻醉下行同种异体肝移植术。n
期刊
目前,对新型冠状病毒肺炎(COVID-19)疫情的关注重点已逐渐转变为疾病对患者的长期影响n [n 1]n 。其中,认知功能可以受到新型冠状病毒——严重急性呼吸综合征相关冠状病毒2(SARS-CoV-2)的影响。研究表明,在3个月的随访中,23%的SARS-CoV-2感染者伴有认知缺陷n [n 2]n ;另有研究提示,该类患者中轻度及中度的意识紊乱比率分别为27%及33%n [n 3,n 4]n 。血脑屏障(BBB)作
期刊
目的:评价异丙酚对小鼠神经干细胞增殖的影响及转录因子特异性蛋白1(Sp1)-表皮生长因子受体(EGFR)-蛋白激酶B(Akt)信号通路在其中的作用。方法:分离和培养C57BL/6小鼠原代神经干细胞,稳定传代后使用免疫荧光染色鉴定。取第3~6代神经干细胞,采用随机数字表法分为3组(n n=21):生理盐水对照组(C组)、异丙酚组(P组)和异丙酚+Sp1抑制剂光神霉素组(PP组)。P组加入终浓度10 μmol/L异丙酚,PP组加入终浓度10 μmol/L异丙酚、终浓度100 nmol/L光神霉素,C
(1)一般情况:患者女性,年龄86岁,身高155 cm,体重60 kg,主因摔倒致右侧髋部疼痛伴活动障碍1 d余入院。患者1 d前因不慎摔倒致右侧髋部疼痛,呈持续性,活动时加重,程度剧烈,伴活动受限及肿胀,X线显示右侧股骨粗隆间骨折。
期刊
麻醉学发展与时俱进,始终致力于改善患者围术期结局,提高急危重症患者的救治能力,以及使患者免受疼痛困扰。自2018年起,笔者对《The Lancet》发表的麻醉学相关研究进行盘点n [n 1,n 2,n 3]n ,以期对国内麻醉学界同道有所借鉴。2021年《The Lancet》共发表13篇与麻醉学领域相关的临床研究或专题综述,探讨危重症及外科患者管理、新型冠状病毒肺炎(COVID-19)患者管理/心肺复苏救治措施、常见类型疼痛的管理等方面。本文对该刊2021年
期刊